Crigler-Najjar Syndrome Type 1: Pathophysiology, Natural History, and Therapeutic Frontier.


Journal

Hepatology (Baltimore, Md.)
ISSN: 1527-3350
Titre abrégé: Hepatology
Pays: United States
ID NLM: 8302946

Informations de publication

Date de publication:
06 2020
Historique:
received: 12 06 2019
accepted: 04 09 2019
pubmed: 26 9 2019
medline: 29 4 2021
entrez: 26 9 2019
Statut: ppublish

Résumé

We describe the pathophysiology, treatment, and outcome of Crigler-Najjar type 1 syndrome (CN1) in 28 UGT1A1 c.222C>A homozygotes followed for 520 aggregate patient-years. Unbound ("free") bilirubin (B Seven decades after its discovery, CN1 remains a morbid and potentially fatal disorder.

Sections du résumé

BACKGROUND AND AIMS
We describe the pathophysiology, treatment, and outcome of Crigler-Najjar type 1 syndrome (CN1) in 28 UGT1A1 c.222C>A homozygotes followed for 520 aggregate patient-years.
APPROACH AND RESULTS
Unbound ("free") bilirubin (B
CONCLUSION
Seven decades after its discovery, CN1 remains a morbid and potentially fatal disorder.

Identifiants

pubmed: 31553814
doi: 10.1002/hep.30959
pmc: PMC7909716
mid: NIHMS1671695
doi:

Substances chimiques

Serum Albumin 0
UGT1A1 enzyme EC 2.4.1.-
Glucuronosyltransferase EC 2.4.1.17
Bilirubin RFM9X3LJ49

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1923-1939

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK120531
Pays : United States

Informations de copyright

© 2019 by the American Association for the Study of Liver Diseases.

Références

Arch Pediatr Adolesc Med. 2000 Apr;154(4):391-4
pubmed: 10768679
Pediatr Res. 2015 Oct;78(4):417-21
pubmed: 26086643
Biochim Biophys Acta. 1980 Oct 1;632(2):290-7
pubmed: 7417528
Pediatrics. 1956 Oct;18(4):614-25
pubmed: 13370229
Cell Mol Neurobiol. 2000 Feb;20(1):97-109
pubmed: 10690504
Pediatrics. 2003 May;111(5 Pt 1):1110-2
pubmed: 12728100
Comp Biochem Physiol A Comp Physiol. 1987;87(4):1003-7
pubmed: 2887366
Hum Mol Genet. 2017 Jan 1;26(1):145-157
pubmed: 28025333
Clin Chem. 1981 May;27(5):692-6
pubmed: 7226493
J Pediatr. 1959 Sep;55:268-79
pubmed: 14428276
J Perinatol. 2009 Apr;29(4):305-9
pubmed: 19242487
J Hepatol. 2017 Aug;67(2):272-281
pubmed: 28412296
J Neuropathol Exp Neurol. 1959 Jan;18(1):165-87; discussion 187-9
pubmed: 13621251
Lancet. 1958 May 24;1(7030):1094-7
pubmed: 13550936
J Pediatr Gastroenterol Nutr. 2018 Apr;66(4):588-594
pubmed: 29176474
Transplant Proc. 2009 Sep;41(7):2875-7
pubmed: 19765461
Pediatrics. 1968 Jun;41(6):1047-54
pubmed: 5652916
Early Hum Dev. 1995 Oct 2;43(2):133-44
pubmed: 8903758
Early Hum Dev. 1979 Dec;3(4):353-72
pubmed: 43803
Liver Transpl. 2006 May;12(5):876-82
pubmed: 16628687
Clin Chem. 2009 Jul;55(7):1288-99
pubmed: 19423734
Am J Med Genet. 1998 Aug 27;79(1):12-5
pubmed: 9738861
Mol Aspects Med. 1987;9(5):473-82
pubmed: 3306242
Neuropediatrics. 2008 Aug;39(4):211-8
pubmed: 19165709
Ann Surg. 1999 Apr;229(4):565-9
pubmed: 10203091
Pediatrics. 1987 Apr;79(4):553-8
pubmed: 3822673
Pediatrics. 1987 Jan;79(1):154-6
pubmed: 3797160
Eur J Pediatr. 2006 May;165(5):306-19
pubmed: 16435131
Hepatology. 1996 Aug;24(2):311-5
pubmed: 8690398
Pediatrics. 1952 Aug;10(2):169-80
pubmed: 12983120
CPT Pharmacometrics Syst Pharmacol. 2018 Jun;7(6):404-412
pubmed: 29637732
J Biol Chem. 1983 May 25;258(10):6319-26
pubmed: 6853485
Pediatrics. 2014 Nov;134(5):e1330-9
pubmed: 25332491
PLoS One. 2011 Jan 31;6(1):e16165
pubmed: 21297965
Nat Med. 2018 Oct;24(10):1519-1525
pubmed: 30297904
Scand J Clin Lab Invest. 1969 Feb;23(1):55-8
pubmed: 5363435
J Child Neurol. 1998 Jun;13(6):265-9
pubmed: 9660509
Pediatrics. 2000 May;105(5):1152-3
pubmed: 10790478
Pediatrics. 1997 Nov;100(5):E9
pubmed: 9347003
Pharmacogenetics. 1997 Aug;7(4):255-69
pubmed: 9295054
J Clin Invest. 1969 Nov;48(11):2176-90
pubmed: 5824077
Acta Paediatr Scand. 1990 Jan;79(1):12-9
pubmed: 2180252
Tunis Med. 2010 Oct;88(10):707-9
pubmed: 20890816
J Perinatol. 2004 Oct;24(10):650-62
pubmed: 15254556
J Pediatr. 2012 Jan;160(1):116-21.e1
pubmed: 21839471
Am J Physiol. 1986 Dec;251(6 Pt 1):C928-34
pubmed: 3789133
Hum Gene Ther. 2014 Sep;25(9):844-55
pubmed: 25072305

Auteurs

Kevin A Strauss (KA)

Clinic for Special Children, Strasburg, PA.
Penn-Lancaster General Hospital, Lancaster, PA.
Departments of Pediatrics and Molecular, Cell & Cancer Biology, University of Massachusetts School of Medicine, Worcester, MA.

Charles E Ahlfors (CE)

Department of Pediatrics, Stanford University School of Medicine, Stanford, CA.

Kyle Soltys (K)

Department of Surgery, Division of Pediatric Transplantation, Hillman Center for Pediatric Transplantation, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA.

George V Mazareigos (GV)

Department of Surgery, Division of Pediatric Transplantation, Hillman Center for Pediatric Transplantation, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA.

Millie Young (M)

Clinic for Special Children, Strasburg, PA.

Lauren E Bowser (LE)

Clinic for Special Children, Strasburg, PA.

Michael D Fox (MD)

Clinic for Special Children, Strasburg, PA.
Department of Pediatrics, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA.
Diagnostic Referral Division, Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE.

James E Squires (JE)

Division of Gastroenterology and Hepatology, Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA.

Patrick McKiernan (P)

Division of Pediatric Gastroenterology, Hepatology and Nutrition, UPMC Children's Hospital of Pittsburgh and Pittsburgh Liver Research Center, Pittsburgh, PA.

Karlla W Brigatti (KW)

Clinic for Special Children, Strasburg, PA.

Erik G Puffenberger (EG)

Clinic for Special Children, Strasburg, PA.

Vincent J Carson (VJ)

Clinic for Special Children, Strasburg, PA.

Hendrik J Vreman (HJ)

Division of Neonatal and Developmental Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH